Fecal Microbiota Transplantation in Patients With Blood Disorders Inhibits Gut Colonization With Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study
- 24 March 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 65 (3), 364-370
- https://doi.org/10.1093/cid/cix252
Abstract
Patients with blood disorders colonized with antibiotic-resistant bacteria (ARB) are prone to systemic infections that are difficult to treat. Reintroduction of commensal bacteria in a murine model of enterococcal colonization of the gut can lead to eradication of enterococci. We hypothesized that fecal microbiota transplantation (FMT) could be used to eradicate ARB in humans. Participants colonized with ARB were treated with intraduodenal FMT according to a prospective protocol (NCT02461199). The primary endpoint was complete ARB decolonization at 1 month after FMT. Secondary endpoints included safety assessment and partial ARB decolonization. Microbiome sequencing was performed to investigate the influence of microbial composition of the transplanted material on the outcome of FMT. Twenty-five FMTs were performed in 20 participants (including 40% who had neutropenia) who were colonized by a median of 2 (range, 1–4) strains of ARB. The primary endpoint was reached in 15/25 (60%) of the FMTs and more frequently in cases in which there was no periprocedural use of antibiotics (79% vs 36%, P < .05). Among participants, 15/20 (75%) experienced complete ARB decolonization. There were no severe adverse events, and partial ARB decolonization was observed in 20/25 (80%) of the FMTs. The microbiota composition analysis revealed higher abundance of Barnesiella spp., Bacteroides, and Butyricimonas and greater bacterial richness in the fecal material, resulting in eradication of Klebsiella pneumoniae compared with nonresponders. FMT in patients with blood disorders is safe and promotes eradication of ARB from the gastrointestinal tract. NCT02461199.Keywords
This publication has 31 references indexed in Scilit:
- Distinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniaePLoS Pathogens, 2015
- Chemotherapy‐driven dysbiosis in the intestinal microbiomeAlimentary Pharmacology & Therapeutics, 2015
- Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUsJAMA, 2014
- Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipientsScandinavian Journal of Infectious Diseases, 2013
- Microbiota-mediated colonization resistance against intestinal pathogensNature Reviews Immunology, 2013
- Leukemia and risk of recurrent Escherichia coli bacteremia: genotyping implicates E. coli translocation from the colon to the bloodstreamEuropean Journal of Clinical Microbiology & Infectious Diseases, 2013
- Country-specific antibiotic use practices impact the human gut resistomeGenome Research, 2013
- Intestinal Microbiota Containing Barnesiella Species Cures Vancomycin-Resistant Enterococcus faecium ColonizationInfection and Immunity, 2013
- Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantationHaematologica, 2010
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concernThe Lancet Infectious Diseases, 2008